These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 13270080)

  • 1. The use of mixed diphtheria-pertussis-tetanus antigens.
    COCKBURN WC
    Bull World Health Organ; 1955; 13(3):409-22. PubMed ID: 13270080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Four years of experience with diphtheria-pertussis-tetanus vaccination: 1000 cases].
    MAZA PEREZ C
    Rev Cubana Pediatr; 1954 Aug; 26(8):531-8. PubMed ID: 13224977
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Broder KR; Cortese MM; Iskander JK; Kretsinger K; Slade BA; Brown KH; Mijalski CM; Tiwari T; Weston EJ; Cohn AC; Srivastava PU; Moran JS; Schwartz B; Murphy TV;
    MMWR Recomm Rep; 2006 Mar; 55(RR-3):1-34. PubMed ID: 16557217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COMPARATIVE CHARACTERISTICS OF PERTUSSIS-DIPHTHERIA, PERTUSSIS-DIPHTHERIA-TETANUS AND SORBED PERTUSSIS-DIPHTERIA-TETANUS VACCINES IN THE IMMUNIZATION OF CHILDREN].
    REZNIK BIa
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Dec; 40():13-7. PubMed ID: 14151776
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
    Dominicus R; Galtier F; Richard P; Baudin M
    Vaccine; 2014 Jun; 32(31):3942-9. PubMed ID: 24852717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple antigen for immunization against poliomyelitis, diphtheria, pertussis, and tetanus. II. Response of infants and young children to primary immunization and eighteen-month booster.
    BARRETT CD; TIMM EA; MOLNER JG; WILNER BI; FAHEY MF; McLEAN IW
    Am J Public Health Nations Health; 1959 May; 49(5):644-55. PubMed ID: 13650011
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials.
    Weston WM; Friedland LR; Wu X; Howe B
    Vaccine; 2012 Feb; 30(9):1721-8. PubMed ID: 22212127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.
    Scott LJ
    BioDrugs; 2010 Dec; 24(6):387-406. PubMed ID: 21043546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.
    Gabutti G
    J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccination against tetanus, diphtheria, pertussis and poliomyelitis in adult travellers.
    Gautret P; Wilder-Smith A
    Travel Med Infect Dis; 2010 May; 8(3):155-60. PubMed ID: 20541135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of routine immunization of children with triple vaccine (diphtheria-tetanus-pertussis).
    IPSEN J; BOWEN HE
    Am J Public Health Nations Health; 1955 Mar; 45(3):312-8. PubMed ID: 14350122
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS;
    MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ON COMBINED IMMUNIZATION BY PERTUSSIS-DIPHTHERIA-TETANUS AND SMALLPOX VACCINES].
    USMANOVA SA
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Sep; 40():30-6. PubMed ID: 14119962
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on combined adsorbed poliomyelitis-DTP vaccine. Poliomyelitis antibody responses of children to primary immunization.
    HALONEN P; KAUHTIO J; LAMY M; LAPINLEIMU K; PENTTINEN K; PERHEENTUPA J; TAMMILEHTO R; TORNBLOM N
    Acta Paediatr (Stockh); 1962 Jul; 51():409-16. PubMed ID: 13903980
    [No Abstract]   [Full Text] [Related]  

  • 19. CURRENT IMMUNIZATION METHODS AND PRECAUTIONS.
    WEHRLE PF
    Calif Med; 1964 Sep; 101(3):153-9. PubMed ID: 14199083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory committee (ACIP).
    MMWR Recomm Rep; 1991 Aug; 40(RR-10):1-28. PubMed ID: 1865873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.